From Our Affiliates

Tag: Ultragenyx

A total of 8 posts are filed under Ultragenyx
Ultragenyx
Ultragenyx Granted Orphan Drug Designation for Triheptanoin for the Treatment of Glucose Transporter Type-1 Deficiency Syndrome
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and… Continue Reading
Ultragenyx
Startup Ultragenyx Snags PiII Program for Growing Rare-Disease Pipeline
Flush from raising more than $100 million, Novato, CA-based startup Ultragenyx Pharmaceutical has stepped up with a new pact to partner on… Continue Reading
Sanfilippo_Foundation_ for_Children
A RARE DISEASE PATIENT PERSPECTIVE – Roy Zeighami
A Rare Disease Patient Perspective I would like to use this blog post to explain why the rare disease community is different, and why it… Continue Reading
Rare_Project_Team_Board
‘R.A.R.E.’ BOARD OF DIRECTORS AND ADVISORS ANNOUNCED
The RARE Project Announces Big Team Additions, Setting the Stage For Continued Success Thirty (30) million people in the US and 350 million… Continue Reading
Wall Street Journal 'Health Blog' Reports – GETTING MORE DRUGS APPROVED FOR RARE DISEASES
By Amy Dockser Marcus A new paper offers a possible road map for getting more drugs approved to treat rare diseases. One key recommendation:… Continue Reading
ultragenyx_logo_Emil_Kakkis
A Rare Disease Pioneer Scores $45 Million for New Company – UltraGenyx
When Emil Kakkis was a researcher at Harbor UCLA developing what would become the first enzyme replacement therapy, he says pharmaceutical… Continue Reading
ultragenyx_logo_Emil_Kakkis
Ultragenyx – Hereditary Inclusion Body Myopathy (HIBM) New Champion for Hope
Rocking It For Rare Disease! If anyone can do it, Dr. Emil Kakkis can.  One of the rare disease communities scientific champions (also one… Continue Reading

Follow us on Twitter